Plaintiffs Want Pfizer Celebrex Docs Unsealed
Plaintiffs in the securities fraud class action against Pfizer Inc. accusing the company of making materially false statements about a clinical study of blockbuster anti-inflammatory drug Celebrex have asked the court...To view the full article, register now.
Already a subscriber? Click here to view full article